Two companies based in Lausanne, Switzerland — ADC Therapeutics and the genomics company SOPHiA Genetics — have signed a deal to identify patients most likely to respond to a blood cancer drug. ADC Therapeutics will send SOPHiA Genetics blood samples collected from an ongoing phase II trial. The trial is testing a treatment for patients […]
The post ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment appeared first on Labiotech.eu.